Genetic test approved for breast cancer treatment

Thursday 23 June 2011

The US Federal Drugs Administration (FDA) has just approved a genetic test that approves candidates for the breast cancer treatment Herceptin. The test analyses the proteins in breast cancer tumours and identifies which are more responsive to treatment with Herceptin.

>> http://m.foxbusiness.com/quickPage.html?page=19453&content=52820974&pageNum=-1


Further information

European Oncology Nursing Society
Avenue E. Mounier 83
B-1200 Brussels
Belgium
Tel: +32 (0)2 779 9923
Fax: +32 (0)2 779 9937
eons.secretariat@cancernurse.eu